Sleep

Sleep Number Announces Partnership With Make-A-Wish® to Provide Quality Sleep for Children With Critical Illnesses

Tuesday, December 1, 2020 - 4:31pm

Today, Giving Tuesday, Sleep Number Corporation (Nasdaq: SNBR) announced a partnership with Make-A-Wish to give the gift of quality sleep to children battling critical illnesses.

Key Points: 
  • Today, Giving Tuesday, Sleep Number Corporation (Nasdaq: SNBR) announced a partnership with Make-A-Wish to give the gift of quality sleep to children battling critical illnesses.
  • This partnership builds on Sleep Numbers dedication to improving the lives of youth through quality sleep.
  • With aligned missions of improving lives, it was a natural fit for Sleep Number to become a Make-A-Wish partner.
  • There is no better way to fulfill our purpose than by gifting comfort and quality sleep to children in need, said Shelly Ibach, President and CEO, Sleep Number.

New Sleep Aid, Sleep, Begins Trial Research

Tuesday, December 1, 2020 - 1:53pm

The preliminary data from the first phase of this trial shows that roughly 90% of users are feeling the effects from this completely natural sleep aid.

Key Points: 
  • The preliminary data from the first phase of this trial shows that roughly 90% of users are feeling the effects from this completely natural sleep aid.
  • It seems that people may, finally, be able to ditch extreme pharmaceutical sleep aids that come with harsh side effects.
  • This is not the case with 'sleep' a revolutionary new sleep aid that mixes small amounts of melatonin with cannabinoids such as CBD, CBN, CBG, and CBC."
  • People with minor sleep issues may experience good results with only CBD, but Hewett is out to develop a powerful, natural sleep aid that can take the place of current pharmaceutical sleep aids.

Purple Will Donate 10% of Net Proceeds from Its Kid Collection Sales For #GivingTuesday to Precious Dreams Foundation

Tuesday, December 1, 2020 - 1:05pm

LEHI, Utah, Dec. 1, 2020 /PRNewswire/ -- Purple Innovation,LLC("Purple"),the leader in comfort innovation and the creator of the renowned Purple Mattress will donate 10 percent of net proceeds from sales of its Kid Collection on Giving Tuesday to the Precious Dreams Foundation.

Key Points: 
  • LEHI, Utah, Dec. 1, 2020 /PRNewswire/ -- Purple Innovation,LLC("Purple"),the leader in comfort innovation and the creator of the renowned Purple Mattress will donate 10 percent of net proceeds from sales of its Kid Collection on Giving Tuesday to the Precious Dreams Foundation.
  • The Precious Dreams Foundation provides bedtime comfort to children in foster care and homeless shelters.
  • The Precious Dreams Foundation will personally deliver these comfort items, called Comfort Drops, throughout the holiday season to shelters and centers across the United States.
  • "Purple and Precious Dreams Foundation are united in our common goal of helping children get the sleep they deserve.

Sleep Cycle Partners with Petit BamBou For Global Relaxation

Tuesday, December 1, 2020 - 9:00am

Sleep Cycle , the worlds most popular intelligent alarm clock app that analyzes users sleep, today announces its first partnership with one of the worlds leading meditation apps, Petit BamBou to provide its global users with relaxation content for better sleep during these uncertain times.

Key Points: 
  • Sleep Cycle , the worlds most popular intelligent alarm clock app that analyzes users sleep, today announces its first partnership with one of the worlds leading meditation apps, Petit BamBou to provide its global users with relaxation content for better sleep during these uncertain times.
  • Sleep Cycle will be hosting meditation content by Petit BamBou in their Sleep Aid program, which features a series of audio productions designed to aid in falling asleep.
  • Implementing a sleep routine that works in meditation can help prepare for a more restful sleep, said Andreas Roman, head of content at Sleep Cycle.
  • With millions of users worldwide, Sleep Cycle has become the worlds richest repository of data on global sleep habits.

Apnimed to Present at World Sleep Virtual Conference

Monday, November 30, 2020 - 12:30pm

Apnimed, a clinical-stage pharmaceutical company focused on advancing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders, today announced that Dr. Luigi Taranto Montemurro, the companys Medical Director will present at the World Sleep Conference, held virtually December 3-5, 2020.

Key Points: 
  • Apnimed, a clinical-stage pharmaceutical company focused on advancing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders, today announced that Dr. Luigi Taranto Montemurro, the companys Medical Director will present at the World Sleep Conference, held virtually December 3-5, 2020.
  • Apnimeds lead product candidate, AD109, targets the neurologic control and facilitates the activation of the upper airway dilator muscles to maintain an open airway during sleep.
  • Apnimed is a clinical-stage pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea patients with Obstructive Sleep Apnea will benefit from treatment with a safe and effective oral medication.
  • Apnimeds lead development program targets the neurologic control of upper airway muscles to maintain an open airway during sleep.

Apnimed to Participate in Fireside Chat at the Evercore ISI HealthCONx Conference

Monday, November 30, 2020 - 12:35pm

Apnimed, a clinical-stage pharmaceutical company focused on advancing medicines to treat Obstructive Sleep Apnea (OSA) and related disorders, today announced that Larry Miller, M.D., Chief Executive Officer, will participate in a fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference, held virtually December 1-3, 2020.

Key Points: 
  • Apnimed, a clinical-stage pharmaceutical company focused on advancing medicines to treat Obstructive Sleep Apnea (OSA) and related disorders, today announced that Larry Miller, M.D., Chief Executive Officer, will participate in a fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference, held virtually December 1-3, 2020.
  • A live webcast of the presentation will be available in the events section of the Apnimed website .
  • Apnimeds lead development program targets the neurologic control of upper airway muscles to maintain an open airway during sleep.
  • Based in Cambridge, Mass., the company is developing a portfolio of novel pharmacologic therapies for sleep apnea and related disorders.

Malamateniah Koutsada says ‘a migrant can dream’ in her new book

Saturday, November 28, 2020 - 5:00am

MELBOURNE, Australia, Nov. 28, 2020 (GLOBE NEWSWIRE) -- A painful past made Malamateniah Koutsada be determined to reach her dreams.

Key Points: 
  • MELBOURNE, Australia, Nov. 28, 2020 (GLOBE NEWSWIRE) -- A painful past made Malamateniah Koutsada be determined to reach her dreams.
  • But I Promised God ( published by Xlibris AU in January 2019), which receives a new marketing campaign tells others to follow their dreams.
  • Koutsada shares her experience during the Greek civil war, by the time she migrated to Australia and her failed marriage.
  • Through this book, she wants her family to learn from her and understand the actions she was taking.

Sleep Apnea Diagnostic and Therapeutic Devices Market Size to Increase Over $2.6 Billion During 2020-2024 | Forecasting Strategy to Undergo a Paradigm Shift From Crisis to New Normal During COVID-19 Pandemic | Technavio

Wednesday, November 25, 2020 - 1:00am

The global sleep apnea diagnostic and therapeutic devices market size is expected to grow by USD 2.62 billion during 2020-2024, progressing at a CAGR of almost 9% during the forecast period.

Key Points: 
  • The global sleep apnea diagnostic and therapeutic devices market size is expected to grow by USD 2.62 billion during 2020-2024, progressing at a CAGR of almost 9% during the forecast period.
  • This has increased the demand for sleep apnea diagnostic and therapeutic devices, such as CPAP devices, which improves the quality of sleep.
  • Global Sleep Apnea Diagnostic And Therapeutic Devices Market: Type
    Based on the type, the market saw maximum growth in the therapeutic devices segment.
  • Global Sleep Apnea Diagnostic And Therapeutic Devices Market: Geographic Landscape
    North America led the market in 2019 with a 43% market share.

Apnimed Announces First Patient Dosed in Phase 2 Clinical Trial with AD109, Lead Candidate for Treatment of Obstructive Sleep Apnea

Tuesday, November 24, 2020 - 12:30pm

Evidence from earlier proof-of-concept studies demonstrated the potential of our oral therapy as an option for the treatment of OSA.

Key Points: 
  • Evidence from earlier proof-of-concept studies demonstrated the potential of our oral therapy as an option for the treatment of OSA.
  • Proof-of-concept for the AD109 program was demonstrated by Apnimed in a Phase 2, parallel group dose-finding study of the combination of atomoxetine and racemic oxybutynin.
  • Apnimed is a clinical-stage pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea patients with Obstructive Sleep Apnea will benefit from treatment with a safe and effective oral medication.
  • Based in Cambridge, Mass., the company is developing a portfolio of novel pharmacologic therapies for sleep apnea and related disorders.

Global Smart Bed Market Report 2020-2026: Growing Attention Towards the Idea of Quality Sleep is Offering High Scope for the Market

Tuesday, November 24, 2020 - 11:00am

The Global Smart Bed Market size is expected to reach $2.7 billion by 2026, rising at a market growth of 4.8% CAGR during the forecast period.

Key Points: 
  • The Global Smart Bed Market size is expected to reach $2.7 billion by 2026, rising at a market growth of 4.8% CAGR during the forecast period.
  • Expanding investments in sleep innovation attributable to the higher adoption of the prosperity of patients are resulting in demand for Smart beds.
  • The expanding significance of quality sleep among adults is paving way for significant investments towards cutting-edge sleep items.
  • Higher occurrences of sleep issues among adults are an essential factor that is drawing a lot of attention towards the idea of quality sleep, in this manner offering high scope for smart beds.